Document is current
Any future updates will be listed below
-
Authors
Herring, Louisa Y
Dallosso, Helen https://orcid.org/0000-0002-6732-0864
Chatterjee, Sudesna
Bodicoat, Danielle
Schreder, Sally
Khunti, Kamlesh
Yates, Tom
Seidu, Sam
Hudson, Ian
Davies, Melanie J
-
Funding
Funding for this research was provided by:
National Institute for Health Research (CLAHRC East Midlands)
- License Information
-
More Information
Article History
Received: 12 December 2017
Accepted: 18 September 2018
First Online: 4 October 2018
Ethics approval and consent to participate
: The trial is sponsored by the University of Leicester (sponsor representative is Dr. Michelle Mueller; uolsponsor@le.ac.uk). Ethical approval was granted on 19 December 2016 by the West Midlands-Solihull National Research Ethics Committee (16/WM/0463) and the Health Research Authority. Written informed consent is provided by the participant before any study data are collected.
: Not applicable.
: LYH, HD, SS, IH, DB, KK, TY, SC and MJD declare that they have no competing interests.SS has acted as a consultant and speaker for Astra Zeneca, Novartis, Novo Nordisk, Sanofi-Aventis, Lilly, Merck Sharp & Dohme, Janssen, and Boehringer Ingelheim. He has received grants in support of implementation research from Janssen. He has served on advisory boards for, Novartis, Novo Nordisk, Sanofi-Aventis, Lilly, Merck Sharp & Dohme, Janssen, and Boehringer Ingelheim.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
